Načítá se...
Cannabinoid-1 (CB1) receptor gene deletion has a compartment-specific affect on the dendritic and axonal availability of mu-opioid receptors and on dopamine axons in the mouse nucleus accumbens
Cannabinoid-type 1 (CB1) receptors are implicated in mu-opioid receptor (mu-OR)-dependent reward ascribed partially to mesolimbic dopamine release in the nucleus accumbens (Acb) shell. Thus, CB1 receptor gene deletion may preferentially alter the availability of mu-ORs and/or dopamine innervation in...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2954666/ https://ncbi.nlm.nih.gov/pubmed/20939059 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/syn.20807 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|